␣ IIb ␤ 3 , a platelet-specific integrin, plays a critical role in platelet aggregation. The affinity of ␣ IIb ␤ 3 for its ligands such as fibrinogen and von Willebrand factor is tightly regulated in an uncharacterized intracellular process termed inside-out signaling. Calcium integrinbinding protein (CIB) has been identified as a protein interacting with the cytoplasmic tail of the ␣ IIb subunit of ␣ IIb ␤ 3 , but its physiological role has not been defined. In the present study, I demonstrate that CIB activates ␣ IIb ␤ 3 both in vitro and in vivo. CIB interacts directly with the ␣ IIb cytoplasmic tail, thereby increasing the affinity of ␣ IIb ␤ 3 for fibrinogen in an in vitro fibrinogenbinding assay. The interaction of CIB with the ␣ IIb cytoplasmic tail is enhanced in a Ca 2؉ -dependent manner. A physiological agonist, ADP, stimulates platelets, activating ␣ IIb ␤ 3 . When the interaction of CIB with the ␣ IIb cytoplasmic tail is blocked in native platelets by a permeable competing peptide, ␣ IIb ␤ 3 activation is not detected even in the presence of ADP. This result indicates that direct interaction of CIB with the ␣ IIb cytoplasmic tail converts ␣ IIb ␤ 3 from a resting to an active conformation. This suggests that CIB plays an important role in one of the pathways that modulate the affinity of ␣ IIb ␤ 3 for its ligand.
␣ IIb ␤ 3 , a platelet-specific integrin, plays a critical role in platelet aggregation. The affinity of ␣ IIb ␤ 3 for its ligands such as fibrinogen and von Willebrand factor is tightly regulated in an uncharacterized intracellular process termed inside-out signaling. Calcium integrinbinding protein (CIB) has been identified as a protein interacting with the cytoplasmic tail of the ␣ IIb subunit of ␣ IIb ␤ 3 , but its physiological role has not been defined. In the present study, I demonstrate that CIB activates ␣ IIb ␤ 3 both in vitro and in vivo. CIB interacts directly with the ␣ IIb cytoplasmic tail, thereby increasing the affinity of ␣ IIb ␤ 3 for fibrinogen in an in vitro fibrinogenbinding assay. The interaction of CIB with the ␣ IIb cytoplasmic tail is enhanced in a Ca 2؉ -dependent manner. A physiological agonist, ADP, stimulates platelets, activating ␣ IIb ␤ 3 . When the interaction of CIB with the ␣ IIb cytoplasmic tail is blocked in native platelets by a permeable competing peptide, ␣ IIb ␤ 3 activation is not detected even in the presence of ADP. This result indicates that direct interaction of CIB with the ␣ IIb cytoplasmic tail converts ␣ IIb ␤ 3 from a resting to an active conformation. This suggests that CIB plays an important role in one of the pathways that modulate the affinity of ␣ IIb ␤ 3 for its ligand.
Integrins are transmembrane receptors that mediate cell adhesion and cell migration. Integrins are heterodimeric integral membrane proteins composed of noncovalently associated ␣ and ␤ subunits (1) (2) (3) . ␣ IIb ␤ 3 , a platelet-specific integrin, is essential for hemostasis by virtue of its role in mediating platelet aggregation and spreading on vascular matrices at sites of injury in the vascular wall (1, 2, 4 -6) . ␣ IIb ␤ 3 is maintained in a resting state on circulating resting platelets. Once activation molecules such as ADP, thrombin, and collagen are generated at these injured sites, they activate nearby circulating platelets, converting ␣ IIb ␤ 3 from a resting to an active conformation in an intracellular process termed inside-out signaling, although its precise mechanisms have been unknown. Active ␣ IIb ␤ 3 binds to specific plasma proteins in solution such as fibrinogen and von Willebrand factor and links platelets together in an aggregate to form a plug (3, 6 -8) .
Considerable effort has been directed toward understanding how the affinity of ␣ IIb ␤ 3 for its ligand is modulated. It is proposed that the ␣ IIb ␤ 3 affinity is modulated through the cytoplasmic tails of both the ␣ IIb and ␤ 3 subunits (9 -11). Truncation of the ␣ IIb cytoplasmic tail induced constitutive activation of ␣ IIb ␤ 3 in transfected Chinese hamster ovary cells (9) . ␤ 3 -endonexin, which associates specifically with the ␤ 3 cytoplasmic tail, was shown to increase the affinity of ␣ IIb ␤ 3 for its ligands in transfected Chinese hamster ovary cells (10) . In addition, it is reported that some other proteins interact with the cytoplasmic tails of ␣ IIb ␤ 3 (11) . However, any molecules that regulate the ␣ IIb ␤ 3 affinity for its ligands by interacting with the ␣ IIb cytoplasmic tail have not been identified. And also, the precise mechanisms that positively and negatively regulate this process in platelets where ␣ IIb ␤ 3 is endogenously expressed have been undefined.
Calcium integrin-binding protein (CIB) 1 was cloned and shown to interact with the cytoplasmic tail of the ␣ subunit of ␣ IIb ␤ 3 in 1997 (12) . CIB, consisting of 191 amino acids, is N-terminally myristoylated and has two Ca 2ϩ binding sites, known as EF-hands I and II. CIB has also been identified as a binding partner for other proteins (13) , but its function has been undefined. In this study, I provide evidence showing that CIB plays an important role in activation of ␣ IIb ␤ 3 in platelets.
EXPERIMENTAL PROCEDURES
Cells Lines, Transfection, Plasmids, Antibodies, and Reagents-Human embryonic kidney 293 cells and human erythroleukemia (HEL) cells from the American Type Culture Collection were maintained in high glucose Dulbecco's modified Eagle's medium and RPMI medium, respectively. Both media were supplemented with 10% fetal calf serum, 1 mM L-glutamine, and antibiotics. Transfection was carried out using SuperFect (Qiagen). The cDNAs encoding various fragments of CIB were generated by PCR from human peripheral blood leukocyte cDNA library (OriGene Technologies, Rockville, IL) and the plasmid pJG4 -5 containing a full-length CIB cDNA. Epitope tag constructs were made by the N-terminal addition of a Myc tag in the pcDNA3 vector (thus creating Myc-CIB) and the C-terminal addition of a FLAG tag in the pCMV-5 (thus creating CIB-FLAG). A polyclonal antibody to CIB was prepared in this study. The synthetic peptide of CIB, NH 2 -EFQHVISR-SPDFASSFKIVL-COOH (residues 172-191) (AnaSpec Inc., San Jose, CA) was used for immunization of rabbits. The antibody was purified by affinity chromatography using the synthetic peptide coupled to Sepharose beads. The monoclonal antibodies specific to the ␤ 3 subunit (clone 1) and an active conformation of ␣ IIb ␤ 3 (PAC-1) were obtained from Transduction Laboratories (San Diego, CA) and Becton Dickinson Immunocytometry Systems, respectively. The monoclonal antibodies to Myc tag (9E10) and GST (B-14) were obtained from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA), and a monoclonal antibody to FLAG tag (M2) was obtained from Sigma. Glutathione-Sepharose and concanavalin A-Sepharose 4B were purchased from Amersham Biosciences, Inc. Anti-Myc-Sepharose was purchased from Santa Cruz Biotechnology.
Yeast Two-hybrid Assay-A cDNA encoding the cytoplasmic tail of the ␣ IIb subunit (residues 989 -1008) was generated by PCR from human peripheral blood leukocyte cDNA library and cloned into pGilda, a yeast expression vector (CLONTECH). The cDNAs encoding various fragments of CIB were amplified from the plasmid pJG4 -5 containing * This work was supported by National Institutes of Health Grant HD39187 (to S. T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. a full-length CIB cDNA and cloned into pJG4 -5 (Invitrogen). A yeast two-hybrid assay was performed as described (14) . Briefly, EGY48 yeast strain was transformed by a LiCl method with pGlida-␣ IIb cytoplasmic tail, pJG4 -5, containing various CIB cDNA fragments and pSH18 -34, a reporter plasmid for ␤-galactosidase assay. Transformants were assayed for Leu prototrophy, and a filter assay was performed for ␤-galactosidase measurement.
In Vitro Binding Assay-The ␣ IIb cytoplasmic tail and CD40 cytoplasmic tail (negative control) were expressed in Escherichia coli (BL21DE) as glutathione S-transferase (GST) fusion proteins (GST-␣ IIb cytoplasmic tail and GST-CD40) and were purified from bacterial lysates by batch elution from glutathione-Sepharose. GST fusion proteins were dialyzed against TBS. CIB (full-length; residues 1-191) tagged at the N terminus with Myc was prepared from 293 cell transfectants using anti-Myc (9E10)-conjugated Sepharose (Santa Cruz Biotechnology). For testing direct interaction of CIB with the ␣ IIb cytoplasmic tail in vitro, 10 g of Myc-CIB was immobilized on anti-Myc-Sepharose. Two g of GST-␣ IIb cytoplasmic tail was incubated with Myc-CIB-immobilized Sepharose. After washing the resin three times with TBS containing 0.05% Triton X-100, bound proteins were eluted and subjected to SDS-PAGE followed by immunoblotting using a monoclonal antibody for GST. For testing the interaction of CIB with the ␣ IIb ␤ 3 and the effect of calcium ion on it, the interaction of GST-CIB with ␣ IIb ␤ 3 was examined. Ten g of concanavalin A-concentrated extracts (␣ IIb ␤ 3 ) was incubated with anti-␤3 monoclonal antibody to ␤ 3 (clone 1; Transduction Laboratories), and ␣ IIb ␤ 3 was immobilized on anti-mouse IgG-Sepharose. After incubation with 2.5 g of purified GST fusion proteins prepared as described above and washing the resins three times with TBS containing 0.05% Triton X-100, GST fusion proteins were eluted and subjected to SDS-PAGE followed by immunoblotting using a monoclonal antibody for GST. For preparation of ␣ IIb ␤ 3 , platelets were washed and lysed in 150 mM NaCl, 1 mM CaCl 2 , 1 mM MgCl 2 , 20 mM Tris-HCl, pH 7.4, containing 50 mM n-octyl ␤-D-glucopyranoside and proteinase inhibitors. ␣ IIb ␤ 3 was enriched from the lysate by batch elution from concanavalin A-Sepharose 4B (15) .
In Vivo Binding Assay-For co-immunoprecipitation of CIB with ␣ IIb subunit, HEL cells were transfected with the pFLAG-CMV-5-CIB only, because HEL cells express ␣ IIb ␤ 3 endogenously. Forty-eight h after transfection, cells were harvested and solubilized in a lysis buffer (150 mM NaCl, 1 mM CaCl 2 , 1 mM MgCl 2 , 20 mM Tris-HCl, pH 7.4, containing 50 mM n-octyl ␤-D-glucopyranoside and proteinase inhibitors). ␣ IIb was immunoprecipitated with a monoclonal anti-␣ IIb antibody (M-148) (Santa Cruz Biotechnology). Immunoprecipitated proteins were subjected to SDS-PAGE and analyzed by immunoblotting using anti-␣ IIb and anti-FLAG (M2) (Sigma).
Fibrinogen-binding Assay-Binding of fibrinogen to ␣ IIb ␤ 3 was examined by using an immunocapture assay as described (15) . A monoclonal antibody to ␤ 3 (clone 1, mouse IgG1) (Transduction Laboratories, San Diego, CA) was coated overnight onto microtiter wells (Flow laboratories, McLean, VA). The wells were washed and blocked with 3% bovine serum albumin, and then ␣ IIb ␤ 3 was captured on the wells. Unbound materials were removed by washing with TBS containing 2 mM CaCl 2 and 2 mM MgCl 2 , and the wells were incubated for 2 h with GST fusion proteins and/or peptides at room temperature. The wells were washed and then incubated for 2 h with 125 I-labeled fibrinogen (300 nM) (Amersham Pharmacia Biotech) at room temperature. The wells were washed three times, and then bound radioactivity was counted.
Peptide Synthesis-A peptide termed CA-2, corresponding to the C-terminal portion of CIB containing the amino acid sequence Arg 179 -Lys 188 (NH 2 -RSPDFASSFK-COOH) and its scrambled version (NH 2 -SDFKSASPFR-COOH) were synthesized by AnaSpec Inc. (San Jose, CA) using a standard solid-phase Fmoc procedure. Corresponding peptides palmitoylated on the N-terminal amino acid were also synthesized in an identical manner. To label peptides with fluorescein isothiocyanate (FITC), 5 mM of peptides were incubated with 4 mg/ml FITC (Sigma) in 50 M Na 2 CO 3 (pH 9.5) at room temperature overnight. The reaction mixture was applied to Sephadex G-50 (Amersham Pharmacia Biotech) (1 ϫ 2 cm) to remove free FITC.
Platelet Stimulation and Fluorescence-activated Cell Sorting Analysis-Platelets were obtained from a regional blood center and healthy volunteers. Blood was collected into 0.15 (v/v) acid-citrate-dextrose (38 mM citric acid, 75 mM sodium citrate, 124 mM dextrose) plus anticoagulant and then centrifuged at 180 ϫ g for 10 min. Platelet-rich plasma was then acidified to pH 6.5 with acid-citrate-dextrose, and PGE 1 (1 M) was added. The platelets were pelleted through plasma by centrifugation at 750 ϫ g for 10 min. The platelet pellet was resuspended in Tyrode's buffer (130 mM NaCl, 10 mM trisodium citrate, 9 mM NaHCO 3 , 6 mM dextrose, 0.9 mM MgCl 2 , 0.81 mM KH 2 PO 4 , 10 mM Tris-HCl, pH 7.4) adjusted to 2 ϫ 10 8 /ml (15, 16) . The platelets were then stimulated with 100 M ADP at 37°C under nonstirring conditions. After 15 min, binding of FITC-labeled PAC-1, an ␣ IIb ␤ 3 -specific, activation-dependent monoclonal antibody (Becton Dickinson Immunocytometry Systems), was analyzed using the FACSort flow cytometer (Becton Dickinson Immunocytometry Systems).
RESULTS

CIB Interacts with the ␣ IIb Cytoplasmic Tail through Its C
Terminus-To identify the region of CIB responsible for interacting with the ␣ IIb cytoplasmic tail, yeast two-hybrid assays using deletion fragments of CIB as a bait were performed. While C-terminal deletion mutants failed to interact with the ␣ IIb cytoplasmic tail, baits containing the C-terminal fragment were positive for the interaction, indicating that the ␣ IIb interacting region resides in the C terminus of CIB (residues 158 -191) (Fig. 1A) .
To confirm that CIB interacts directly with the ␣ IIb cytoplasmic tail, in vitro binding assays were performed. GST-␣ IIb cytoplasmic tail (GST-␣ IIb C-tail) was incubated with Myctagged recombinant CIB (Myc-CIB) immobilized on anti-MycSepharose. As shown in Fig. 1B , Myc-CIB interacted directly with the GST-␣ IIb cytoplasmic tail (Fig. 1B, lane 2) , whereas a negative control, Myc-tagged Siah (Drosophila seven in absentia homologous protein) (14) failed to interact with the GST-␣ IIb cytoplasmic tail (Fig. 1B, lane 1) .
To examine whether CIB interacts with the ␣ IIb cytoplasmic tail in cells, co-immunoprecipitation analysis of lysates from transfected cells was performed. HEL cells, a human erythroleukemic cell line that endogenously expresses ␣ IIb ␤ 3 , were transiently transfected with FLAG-tagged CIB constructs, because the endogenous expression of CIB is too low to detect. CIB was tagged with FLAG at the C terminus, since the Nterminally tagged construct of CIB failed to be N-myristoylated, and N-myristoylation is critical in correct localization of CIB in cells (13) . FLAG-tagged full-length CIB was co-immunoprecipitated with ␣ IIb subunit (Fig. 1C, lane 2) , indicating that CIB interacts with the ␣ IIb cytoplasmic tail in cells.
Interaction of CIB with the ␣ IIb Cytoplasmic Tail Is Enhanced in a Ca
2ϩ -dependent Manner-Because CIB is a calcium-binding protein, we then asked whether the interaction of CIB with the ␣ IIb cytoplasmic tail is affected by Ca 2ϩ . To address this question, the in vitro interaction of CIB with ␣ IIb ␤ 3 was tested for the influence of Ca 2ϩ concentration. GST-CIB bound to ␣ IIb ␤ 3 in the presence of either EGTA or 100 nM of CaCl 2 , which is equivalent to the Ca 2ϩ concentration observed in resting platelets (17) (Fig. 2, lanes 3 and 4) . In the presence of 10 M CaCl 2 , binding of GST-CIB to ␣ IIb ␤ 3 was enhanced about 3 times more than in the presence of 100 nM CaCl 2 as determined densitometric analysis (Fig. 2, lane 5) . Ten M CaCl 2 is equivalent to the Ca 2ϩ concentration in ADP-stimulated platelets (17) . These results suggest that the interaction of CIB with the ␣ IIb cytoplasmic tail must be enhanced in ADP-stimulated platelets compared with resting platelets. When ␣ IIb ␤ 3 was incubated with GST-CIB in the presence of excess amounts of the GST-␣ IIb cytoplasmic tail, binding of GST-CIB to ␣ IIb ␤ 3 was not detected (Fig. 2, lane 6) , indicating that GST-CIB binds to ␣ IIb ␤ 3 through the cytoplasmic tail of ␣ IIb .
CIB Activates ␣ IIb ␤ 3 in Vitro-Binding of physiological ligands to ␣ IIb ␤ 3 expressed on agonist-stimulated platelets is an initial and critical step in platelet aggregation. The observation of a direct interaction of CIB with the cytoplasmic tail of ␣ IIb in cells raised the possibility that CIB modulates the affinity of ␣ IIb ␤ 3 for its ligand in platelets. To test this possibility, the effects of CIB on the affinity of ␣ IIb ␤ 3 for fibrinogen, one of its physiological ligands, were first examined in an in vitro immunocapture assay using 125 I-labeled fibrinogen. Binding of fibrinogen to ␣ IIb ␤ 3 dramatically increased in a dose-dependent manner following the addition of GST-CIB, whereas a negative Binding of fibrinogen to ␣ IIb ␤ 3 was measured in the presence of CA-2. Scrambled CA-2 was also used as a control. In A-C, all of the results were expressed as the mean Ϯ S.E. The analysis was performed three times independently, and one representative result is shown.
FIG. 2. Interaction of CIB with the ␣ IIb cytoplasmic tail is enhanced in a Ca
2؉ -dependent manner. ␣ IIb ␤ 3 was prepared from platelet extracts using concanavalin A-Sepharose. GST fusion proteins, GST-CIB, GST-␣ IIb cytoplasmic tail, and GST-CD40 were purified from bacterial extracts (BL21) with glutathione-Sepharose. control, GST-CD40, did not increase binding (Fig. 3A) . Binding was efficiently inhibited by NH 2 -GRGDSP-COOH RGD peptide but not by NH 2 -GRGESP-COOH RGE peptide (Invitrogen), indicating that fibrinogen binds to a physiological binding site of ␣ IIb ␤ 3 in this assay (Fig. 3A) . The increase in the fibrinogen binding to ␣ IIb ␤ 3 by GST-CIB is 77-84% of the fibrinogen binding to activated ␣ IIb ␤ 3 from ADP-stimulated platelets (Fig.  3A, open bar) . This result suggests that the interaction of GST-CIB with the ␣ IIb cytoplasmic tail triggers a structural change in the extracellular domain of ␣ IIb ␤ 3 so that fibrinogen can bind to it and that the structural change of ␣ IIb ␤ 3 by GST-CIB is nearly equivalent to that of activated ␣ IIb ␤ 3 prepared from agonist-stimulated platelets.
To confirm that the increase in fibrinogen binding to ␣ IIb ␤ 3 is due to direct interaction of CIB with the ␣ IIb cytoplasmic tail, the interaction was inhibited with a synthetic peptide. To do so, several different peptides were synthesized based on the amino acid sequence of the region of CIB (residues 158 -191) that interacts with the ␣ IIb cytoplasmic tail (Fig. 1A) . Among those, a peptide designated CA-2 (NH 2 -RSPDFASSFK-COOH), corresponding to the C terminus of CIB (residues 179 -188), efficiently inhibited interaction of CIB with the GST-␣ IIb cytoplasmic tail in an in vitro binding assay (Fig. 3B) . Binding of fibrinogen to ␣ IIb ␤ 3 was reduced in the presence of CA-2 ( Fig.  3C) , while a control peptide, which is a scrambled version of CA-2 (scCA-2), had no effect on the binding (Fig. 3C) , indicating that the increase in fibrinogen binding to ␣ IIb ␤ 3 is a consequence of the direct interaction of CIB with the ␣ IIb cytoplasmic tail.
CIB Activates ␣ IIb ␤ 3 in Vivo-When platelets are stimulated with physiological agonists such as ADP and thrombin, ␣ IIb ␤ 3 is activated, increasing its affinity for fibrinogen. The next question is whether CIB plays a role in increasing the affinity of ␣ IIb ␤ 3 for fibrinogen in platelets where ␣ IIb ␤ 3 is endogenously expressed. To address this question, ␣ IIb ␤ 3 activation was examined while the interaction of CIB with the ␣ IIb cytoplasmic tail was inhibited in intact platelets. To inhibit this interaction, CA-2 was introduced directly into platelets, since platelets are not amenable to direct genetic manipulation. Charged peptides such as CA-2 can be introduced into cells by palmitoylation, which overcomes the inability of a charged peptide to penetrate the plasma membrane (15, 16) . When platelets were stimulated with ADP, ␣ IIb ␤ 3 was activated as determined by high affinity binding of PAC-1, a monoclonal antibody specific for an active conformation of ␣ IIb ␤ 3 (Fig. 4, A  and B) . However, no significant PAC-1 binding was detected even in the presence of ADP, when platelets were preincubated with palmitoylated CA-2 (pCA-2) to block the interaction of CIB with the ␣ IIb cytoplasmic tail (Fig. 4C) . By contrast, when platelets were preincubated with a palmitoylated control peptide (pscCA-2), PAC-1-binding was detected at a level identical to that achieved without pCA-2 and in the presence of ADP (Fig. 4D) . When platelets were preincubated with nonpalmitoylated CA-2 and palmitic acid, PAC-1-binding was also detected -2 (open histogram) . G, total lysates prepared from resting and ADP-stimulated platelets were analyzed by immunoblotting with anti-CIB polyclonal antibody. (Fig. 4E) . To confirm that the palmitoylated peptides enter the platelets, the cell permeability of FITC-labeled peptide with and without palmitate was examined. Platelets were incubated for 1-2 min with 100 M FITC-labeled CA-2 or FITC-labeled pCA-2, washed extensively, and then analyzed by flow cytometry. Fig. 4F showed that only the palmitoylated FITC-labeled CA-2 (closed histogram) had significant cellular association, indicating that pCA-2 is cell-permeable. These results indicate that pCA-2 inhibits ␣ IIb ␤ 3 activation by blocking the interaction of CIB with ␣ IIb in ADP-stimulated platelets. This finding is consistent with the findings shown above that inhibition of CIB interaction with the ␣ IIb cytoplasmic tail reduced the affinity of ␣ IIb ␤ 3 for fibrinogen in vitro (Fig. 3C) . No changes in the expression level of CIB after ADP stimulation were observed (Fig. 4G) . These results, taken together demonstrate that direct interaction of CIB with the ␣ IIb cytoplasmic tail converts ␣ IIb ␤ 3 from a resting to an active conformation in native platelets.
DISCUSSION
When platelets are stimulated with physiological agonists such as ADP, ␣ IIb ␤ 3 is converted from a resting to an active conformation (Fig. 4, A and B) . ␣ IIb ␤ 3 activation is induced by the interaction of CIB with the ␣ IIb cytoplasmic tail (Figs. 3 and 4, C-E). No changes in the expression level of CIB were detected after ADP stimulation (Fig. 4G ). These observations suggest that inside-out signaling enhances the interaction of CIB with the ␣ IIb cytoplasmic tail, inducing a conformational change in the extracellular domain of ␣ IIb ␤ 3 expressed on agonist-stimulated platelets.
It is possible that an increase in the intracellular Ca 2ϩ concentration resulting from agonist stimulation may account for the increase in the affinity of CIB for the ␣ IIb cytoplasmic tail in platelets, since the interaction of CIB with the ␣ IIb ␤ 3 cytoplasmic tail was enhanced in a Ca 2ϩ -dependent manner (Fig. 2) . Shock et al. also reported that binding of CIB to the ␣ IIb cytoplasmic domain peptide is enhanced in a Ca 2ϩ -dependent manner (18) .
Another factor that may increase the affinity of CIB for the ␣ IIb cytoplasmic tail is a change in its subcellular localization dependent upon Ca 2ϩ concentration. CIB is a member of the calcium-myristoyl-switch protein family (19, 20) . The members of this family include recoverin, GCAP, and frequenin and others, and all have both a myristoyl tag and Ca 2ϩ binding sites (EF-hands) (20) . Structural analyses reveal that the myristoyl tag is sequestered inside the protein in the absence of Ca 2ϩ and that binding of Ca 2ϩ to the protein leads to the extrusion of its myristoyl tag, making it available to interact with membrane targets (19) . An increase in intracellular Ca 2ϩ concentration following agonist stimulation in platelets may make CIB available to interact with the ␣ IIb cytoplasmic tail by recruiting CIB to the membrane. This would result in an increase in the affinity of CIB for the ␣ IIb cytoplasmic tail, thereby activating ␣ IIb ␤ 3 .
In contrast to the results shown in Fig. 3 Such a discrepancy probably comes from the differences in assay methods. First, Vallar et al. (21) performed the entire ␣ IIb ␤ 3 -CIB binding assay in a liquid phase, while in the present study, CIB was added to ␣ IIb ␤ 3 immunocaptured onto wells. Immunocaptured ␣ IIb ␤ 3 may be more concentrated on the surface of the wells, resulting in an increase in assay sensitivity. Second, in the study of Vallar et al. (21) , ␣ IIb ␤ 3 activation was evaluated by the amounts of the active form of ␣ IIb ␤ 3 immunoprecipitated with PAC-1. By contrast, binding of fibrinogen to ␣ IIb ␤ 3 was measured in Fig. 3 . Considering the efficiency of immunoprecipitation with PAC-1, measurement of fibrinogen binding is more sensitive, quantitative, and physiologically relevant than their assay method. Finally, in this study, the ␣ IIb ␤ 3 -activating activity of CIB was confirmed in an experiment using intact platelets (Fig. 4) .
One highly plausible mechanism for the ␣ IIb ␤ 3 affinity modulation for its ligand is proposed (6, 15) . The cytoplasmic tails of the ␣ IIb and ␤ 3 interact with each other possibly through a salt bridge, maintaining ␣ IIb ␤ 3 in a latent state. Inside-out signaling induces the dissociation of the interaction between the cytoplasmic tails of ␣ IIb and ␤ 3 , thereby converting a conversion of the extracellular domain of ␣ IIb ␤ 3 from the latent to an active conformation. CIB may act as an positive regulator to dissociate this interaction by interacting with the ␣ IIb cytoplasmic tail. Future studies will be important to determine how the interaction of CIB with the ␣ IIb cytoplasmic tail is regulated.
In conclusion, the results of this study demonstrate that CIB is a key player in the modulation of ␣ IIb ␤ 3 affinity for its ligand in platelets.
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